Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Fleming

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Cancer Discovery|April 17, 2018
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven CancersVivek Subbiah, Justin F Gainor, Rami Rahal, et al.
JAMA Network Open|May 6, 2024
Whole-Body Hypothermia vs Targeted Normothermia for Neonates With Mild Encephalopathy: A Multicenter Pilot Randomized Clinical TrialPaolo Montaldo, Mario Cirillo, Constance Burgod, et al.
Science Translational Medicine|May 29, 2024
An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressivaAlison J Davis, Natasja Brooijmans, Jason D Brubaker, et al.
Nature Medicine|January 16, 2018
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatmentMarc L Hyer, Michael A Milhollen, Jeff Ciavarri, et al.
Journal of Clinical Microbiology|August 27, 2025
Analytical evaluation of TriVerity, a rapid diagnostic and prognostic host gene expression test performed on the Myrna instrument using RT-LAMPClaudia Figueiredo-Pereira, Paul Fleming, Mikaela Nicole Alganes, et al.
Nature|May 29, 2024
A contact binary satellite of the asteroid (152830) DinkineshHarold F Levison, Simone Marchi, Keith S Noll, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Cancer Discovery|April 17, 2018
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven CancersVivek Subbiah, Justin F Gainor, Rami Rahal, et al.
JAMA Network Open|May 6, 2024
Whole-Body Hypothermia vs Targeted Normothermia for Neonates With Mild Encephalopathy: A Multicenter Pilot Randomized Clinical TrialPaolo Montaldo, Mario Cirillo, Constance Burgod, et al.
Science Translational Medicine|May 29, 2024
An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressivaAlison J Davis, Natasja Brooijmans, Jason D Brubaker, et al.
Nature Medicine|January 16, 2018
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatmentMarc L Hyer, Michael A Milhollen, Jeff Ciavarri, et al.
Journal of Clinical Microbiology|August 27, 2025
Analytical evaluation of TriVerity, a rapid diagnostic and prognostic host gene expression test performed on the Myrna instrument using RT-LAMPClaudia Figueiredo-Pereira, Paul Fleming, Mikaela Nicole Alganes, et al.
Nature|May 29, 2024
A contact binary satellite of the asteroid (152830) DinkineshHarold F Levison, Simone Marchi, Keith S Noll, et al.
Pageof 7